论文部分内容阅读
目的研究人结肠癌耐药细胞系的耐药机制.方法采用抗P糖蛋白单抗JSB1和MRK16以免疫细胞化学染色法(ABC)检测HCTV2000及亲本HCT8细胞的P糖蛋白表达;提取两种细胞的DNA和RNA,与探针PHDR5A杂交检测耐药基因mdr1的表达和扩增;MTT法测定VCR对两种细胞的细胞毒作用.结果细胞系HCTV2000对抗P糖蛋白单抗呈阳性反应,编码P糖蛋白的多药耐药基因mdr1过度表达,但未见扩增或重排.异博定(10μg/ml)使HCTv2000细胞内3HVCR蓄积增加将近4倍,对VCR的敏感性提高84倍,可部分逆转耐药.结论多药耐药基因mdr1mRNA过度表达是HCTV2000细胞耐药的重要原因,但还有其他机制参与
Objective To study the resistance mechanism of human colon cancer drug-resistant cell lines. Methods The expression of Pglycoprotein in HCTV2000 and parental HCT8 cells was detected by immunocytochemical staining (ABC) using anti-Pglycoprotein monoclonal antibodies JSB1 and MRK16; the DNA and RNA of the two cells were extracted. The probe PHDR5A hybridization was used to detect the expression and amplification of mdr1 gene; MTT assay was used to determine the cytotoxic effect of VCR on both cells. Results The cell line HCTV2000 reacted positively against the P glycoprotein monoclonal antibody, and the multidrug resistance gene mdr1 encoding P glycoprotein was over-expressed, but no amplification or rearrangement was observed. Isobrindidine (10μg/ml) increased the accumulation of 3H-VCR in HCTv2000 cells by nearly 4-fold and the sensitivity to VCR by 84-fold, partially reversing drug resistance. Conclusion The overexpression of multidrug resistance gene mdr1 mRNA is an important cause of drug resistance in HCTV2000 cells, but there are other mechanisms involved